Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

OBJECTIVES: The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart Association class II chronic heart failure and reduced left ventricular ejection fraction from the perspective of the Greek national he...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinicoecon Outcomes Res
Main Authors: Athanasakis, Kostas, Bilitou, Aikaterini, Lee, Dawn, Karampli, Eleftheria, Karavidas, Apostolos, Parissis, John, Sykara, Georgia, Kyriopoulos, John
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066703/
https://ncbi.nlm.nih.gov/pubmed/27785081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S107831
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados